- Total raised
- $612M
- Stage
- Series C
- Hiring pace
- 7 roles / 90d
- Team size
- 201-500 employees
- Founded
- 2019
- HQ
- South San Francisco
About Cellares
Accelerating Access to Life-Saving Cell Therapies
Open roles · 5
- Open
Director, Global Field Service Engineering
Bridgewater, NJ · on-site · $170k–240k
- Open
Senior Systems Engineer
South San Francisco, CA · on-site · $124k–138k
- Open
Quality Control Raw Material Analyst
Bridgewater, NJ · on-site · $90k–210k
- Open
Facilities Maintenance Engineer
Bridgewater, NJ · on-site · $90k–210k
- Open
Supervisor, Manufacturing
South San Francisco, CA · on-site · $90k–210k
Location
More startups in South San Francisco
Cognition
San Francisco
The company is an applied AI lab that builds end-to-end software agents and collaborative AI teammates, enabling engineers to focus on more interesting problems and empowering teams to pursue ambitious goals; it markets Devin as the first A
Thinking Machines Lab
San Francisco
Thinking Machines Lab is a San Francisco AI research startup founded in 2025 by former OpenAI CTO Mira Murati, building interpretable, collaborative AI systems for professional and enterprise use. Its first product, Tinker, helps developers fine-tune models without managing distributed infrastructure.
Mind Robotics
Palo Alto
Mind Robotics develops artificial intelligence and robotics systems designed for industrial environments and manufacturing operations.
Xaira Therapeutics
South San Francisco
an integrated biotechnology company driving advances in AI to transform how we treat disease.
Poolside
San Francisco
Poolside is building the world's most capable AI for software development, focusing on distributed training and inference of large language models for source code generation, with a mission to unlock developers' potential through AI for sof
The Bot Company
San Francisco
The Bot Company builds household robots to give people back time, pursuing in-house AI, software and hardware. It plans to deploy millions at home before expanding, and has raised $300M, including a $150M Greenoaks-led round, valuing the co
